JAK抑制剂
英文名 | Tofacitinib citrate | CAS号 | 540737-29-9 |
试剂别名 |
Tofacitinib (Tasocitinib, CP-690550);Tofacitinib (CP-690550) Citrate;CP-690550 Citrate (Tofacitinib Citrate);1-PIPERIDINEPROPANENITRILE, 4-METHYL-3-(METHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YLAMINO)-BETA-OXO-, (3R,4R)-, 2-HYDROXY-1,2...;CP 690,550;CP 690550 citrate;Tasocitinib citrate;Tasocitinib citric acid salt;tofacitinib;Tofacitinib citrate;Tofacitinib citrate(CP690550);TOFACITINIB, CITRATE SALT;Tofacititinib cirate;2-hydroxypropane-1,2,3-tricarboxylic acid,3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile;3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate;citro;CP-690,550-10;CP-690550 citrate;Xeljanz;(3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile citrate salt;3-[(3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile citrate salt;CP-690550-10;Tasocitinib citrate salt;(3R,4R)-1-(Cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-3-piperidinamine 2-hydroxy-1,2,3-propanetricarboxylate;CP 690500-10;CP 690550-10;(3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-1-piperidinepropanenitrile 2-Hydroxy-1,2,3-propanetricarboxylate
|
分子式 | C16H20N6O.C6H8O7 |
产品编号 | APEA4135 | 分子量 | 504.49 |
MDL号 | MFCD11616529 |
产品名称: | JAK抑制剂 |
英文名称: | Tofacitinib citrate |
英文别名: | Tofacitinib (Tasocitinib, CP-690550);Tofacitinib (CP-690550) Citrate;CP-690550 Citrate (Tofacitinib Citrate);1-PIPERIDINEPROPANENITRILE, 4-METHYL-3-(METHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YLAMINO)-BETA-OXO-, (3R,4R)-, 2-HYDROXY-1,2...;CP 690,550;CP 690550 citrate;Tasocitinib citrate;Tasocitinib citric acid salt;tofacitinib;Tofacitinib citrate;Tofacitinib citrate(CP690550);TOFACITINIB, CITRATE SALT;Tofacititinib cirate;2-hydroxypropane-1,2,3-tricarboxylic acid,3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile;3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate;citro;CP-690,550-10;CP-690550 citrate;Xeljanz;(3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile citrate salt;3-[(3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile citrate salt;CP-690550-10;Tasocitinib citrate salt;(3R,4R)-1-(Cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-3-piperidinamine 2-hydroxy-1,2,3-propanetricarboxylate;CP 690500-10;CP 690550-10;(3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-1-piperidinepropanenitrile 2-Hydroxy-1,2,3-propanetricarboxylate |
中文别名: | 托法替尼 |
CAS No.: | 540737-29-9 |
分子式: | C16H20N6O.C6H8O7 |
分子量: | 504.49 |
危险品级别: | |
HS符号: | |
危害声明: |